Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury

• Published in: Intensive care medicine experimental Vol. 12; no. 1; pp. 53 - 13
• Main Authors: Garcia, Bruno, ter Schiphorst, Benoit, Santos, Karine, Su, Fuhong, Dewachter, Laurence, Vasques-Nóvoa, Francisco, Rocha-Oliveira, Estela, Roncon-Albuquerque, Roberto, Uba, Theo, Hartmann, Oliver, Picod, Adrien, Azibani, Feriel, Callebert, Jacques, Goldman, Serge, Annoni, Filippo, Favory, Raphaël, Vincent, Jean-Louis, Creteur, Jacques, Taccone, Fabio Silvio, Mebazaa, Alexandre, Herpain, Antoine
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 07-06-2024; Springer Nature B.V; SpringerOpen
• Subjects: Angiotensin II; Catecholamines; Critical Care Medicine; Cytokines; Dipeptidyl peptidase 3; Intensive; Intensive care; Medicine; Medicine & Public Health; Renin–angiotensin system; Sepsis; Shock; Vasopressors; Renin–angiotensin system; Shock; Sepsis; Vasopressors; Dipeptidyl peptidase 3; Angiotensin II
• ISSN: 2197-425X; 2197-425X
• DOI: 10.1186/s40635-024-00638-3

Background
Dipeptidyl peptidase 3 (DPP3) is a ubiquitous cytosolic enzyme released into the bloodstream after tissue injury, that can degrade angiotensin II. High concentrations of circulating DPP3 (cDPP3) have been associated with worse outcomes during sepsis. The aim of this study was to assess the effect of Procizumab (PCZ), a monoclonal antibody that neutralizes cDPP3, in an experimental model of septic shock.
Methods
In this randomized, open-label, controlled study, 16 anesthetized and mechanically ventilated pigs with peritonitis were randomized to receive PCZ or standard treatment when the mean arterial pressure (MAP) dropped below 50 mmHg. Resuscitation with fluids, antimicrobial therapy, peritoneal lavage, and norepinephrine was initiated one hour later to maintain MAP between 65–75 mmHg for 12 h. Hemodynamic variables, tissue oxygenation indices, and measures of organ failure and myocardial injury were collected. Organ blood flow was assessed using isotopic assessment (
99m
technetium albumin). cDPP3 activity, equilibrium analysis of the renin–angiotensin system and circulating catecholamines were measured. Tissue mRNA expression of interleukin-6 and downregulation of adrenergic and angiotensin receptors were assessed on vascular and myocardial samples.
Results
PCZ-treated animals had reduced cDPP3 levels and required less norepinephrine and fluid than septic control animals for similar organ perfusion and regional blood flow. PCZ-treated animals had less myocardial injury, and higher PaO
2
/FiO
2
ratios. PCZ was associated with lower circulating catecholamine levels; higher circulating angiotensin II and higher angiotensin II receptor type 1 myocardial protein expression, and with lower myocardial and radial artery mRNA interleukin-6 expression.
Conclusions
In an experimental model of septic shock, PCZ administration was associated with reduced fluid and catecholamine requirements, less myocardial injury and cardiovascular inflammation, along with preserved angiotensin II signaling.
Graphical Abstract